Caitlin Cheshire

Caitlin Cheshire

Auto-generated profile, based on publicly available information

Caitlin Cheshire

Department of Cardiology, The Alfred, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2023 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
DMDavid McGiffin
David McGiffin
CKChristina E. Kure
Christina E. Kure
PMPeter S. Macdonald
Peter S. Macdonald
PJPaul C. Jansz
Paul C. Jansz
SESam Emmanuel
Sam Emmanuel
DKDavid M. Kaye
David M. Kaye

11 July 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
CCCaitlin Cheshire
Caitlin Cheshire
SMSimon Messer
Simon Messer
LMLuis Martinez
Luis Martinez
IVIsmail Vokshi
Ismail Vokshi
JAJason Ali
Jason Ali
SBSai Bhagra
Sai Bhagra
Experience in donation after circulatory-determined death (DCD) heart transplantation (HTx) is expanding. There is limited information on the functional outcomes of DCD HTx recipients. We sought to evaluate functional outcomes in our cohort of DCD recipients. We performed a single-center, retrospective, observational cohort study comparing outcomes in consecutive DCD and donation after brain death (DBD) HTx recipients between 2015 and 2019. Primary outcome was allograft function by echocardiography at 12 and 24 months. Secondary outcomes included incidence of cardiac allograft vasculopathy, treated rejection, renal function, and survival. Seventy-seven DCD and 153 DBD recipients were included. There was no difference in left ventricular ejection fraction at 12 months (59% vs 59%, P = .57) and 24 months (58% vs 58%, P = .87). There was no significant difference in right ventricular function at 12 and 24 months. Unadjusted survival between DCD and DBD recipients at 5 years (85.7% DCD and 81% DBD recipients; P = .45) was similar. There were no significant differences in incidence of cardiac allograft vasculopathy (odds ratio 1.59, P = .21, 95% confidence interval 0.77-3.3) or treated rejection (odds ratio 0.60, P = .12, 95% confidence interval 0.32-1.15) between DBD and DCD recipients. Post-transplant renal function was similar at 1 and 2 years. In conclusion, cardiac allografts from DCD donors perform similarly to a contemporary population of DBD allografts in the medium term.

17 December 2020 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
CCCaitlin Cheshire
Caitlin Cheshire
AKAnna Kydd
Anna Kydd
NNNitesh Nerlekar
Nitesh Nerlekar
PCPedro Catarino
Pedro Catarino
ABAdam Brown
Adam Brown
SPStephen Pettit
Stephen Pettit

21 July 2022 in Clinical Transplantation
Verified
Journal Article
Closed access
CCCaitlin Cheshire
Caitlin Cheshire
RQRichard Quigley
Richard Quigley
SCSarah Claydon
Sarah Claydon
SJSadie Von Joel
Sadie Von Joel
MOMohamed Osman
Mohamed Osman
SPStephen Pettit
Stephen Pettit